Wolverine Trading, LLC Rigel Pharmaceuticals Inc Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.12 - $1.57 $14,290 - $20,031	12,759 New	12,759 $18,000
Q1 2021 May 14, 2021	BUY	$3.35 - $4.93 $12,297 - $18,098	3,671 Added 25.83%	17,883 $61,000
Q3 2020 Nov 13, 2020	BUY	$1.78 - $4.13 $25,297 - $58,695	14,212 New	14,212 $33,000
Q1 2019 May 15, 2019	SELL	$2.0 - $2.65 $70,358 - $93,224	-35,179 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $25,627 - $41,398	12,321 Added 53.9%	35,179 $79,000
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $18,192 - $25,119	6,997 Added 44.11%	22,858 $73,000
Q1 2018 May 15, 2018	SELL	$3.54 - $4.54 $52,413 - $67,219	-14,806 Reduced 48.28%	15,861 $56,000
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $99,054 - $131,868	30,667	30,667 $119,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.